Patents by Inventor Dominique F. Bonafoux

Dominique F. Bonafoux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL TRICYCLIC COMPOUNDS
    Publication number: 20130072470
    Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
    Type: Application
    Filed: September 20, 2012
    Publication date: March 21, 2013
    Applicant: ABBVIE INC.
    Inventors: Neil Wishart, Dominique F. Bonafoux, Kristine E. Frank, Adrian D. Hobson, Donald B. Konopacki, Gloria Y. Martinez, Lu Wang
  • Triazolopyridazines
    Patent number: 8188083
    Abstract: The present invention is directed to novel compounds of formula (I) wherein the variables are defined as herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: May 29, 2012
    Assignee: Abbott Laboratories
    Inventors: David J. Calderwood, Dominique F. Bonafoux, Andrew Burchat, Ping Ding, Kristine E. Frank, Michael Z. Hoemann, Kelly D. Mullen, Heather M. Davis
  • Thienopyrroles and pyrrolothiazoles as new therapeutic agents
    Patent number: 8101645
    Abstract: The present invention is directed to novel compounds of Formula (I) wherein the variables are defined as herein. The compounds of Formula (I) are useful as CRTH2 antagonists and as such would be useful in treating certain conditions and diseases, especially asthma, allergic asthma, allergic inflammation, rhinitis, allergic rhinitis or atopic dermatitis.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: January 24, 2012
    Assignee: Abbott Laboratories
    Inventors: Dominique F. Bonafoux, Xiaoyun Wu
  • Novel triazolopyridazines
    Publication number: 20090270402
    Abstract: The present invention is directed to novel compounds of formula (I) wherein the variables are defined as herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.
    Type: Application
    Filed: June 26, 2008
    Publication date: October 29, 2009
    Inventors: David J. Calderwood, Dominique F. Bonafoux, Andrew Burchat, Ping Ding, Kristine E. Frank, Michael Z. Hoemann, Kelly D. Mullen, Heather M. Davis
  • Thienopyrroles and pyrrolothiazoles as new therapeutic agents
    Publication number: 20090209609
    Abstract: The present invention is directed to novel compounds of Formula (I) wherein the variables are defined as herein. The compounds of Formula (I) are useful as CRTH2 antagonists and as such would be useful in treating certain conditions and diseases, especially asthma, allergic asthma, allergic inflammation, rhinitis, allergic rhinitis or atopic dermatitis.
    Type: Application
    Filed: February 13, 2009
    Publication date: August 20, 2009
    Inventors: Dominique F. Bonafoux, Xiaoyun Wu